Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Qiming Wang et al.|Journal of Thoracic Oncology|2021Cited by 311
Atractylenolide III predisposes miR‐195‐5p/FGFR1 signaling axis to exert tumor‐suppressive functions in liver cancerLangqing Sheng, Ze‐Guo Chen, Jiarong Li et al.|Journal of Food Biochemistry|2021Cited by 18
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Xiaofeng Zeng, Ying Jiang et al.|Annals of the Rheumatic Diseases|2025Cited by 17
Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosisLangqing Sheng, Nianfeng Li, Jiarong Li et al.|World Journal of Gastrointestinal Oncology|2020Cited by 13